Twist Bioscience Corp (TWST)
41.95
+0.38
(+0.91%)
USD |
NASDAQ |
Nov 04, 13:13
Twist Bioscience Revenue (Quarterly): 81.46M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 81.46M |
March 31, 2024 | 75.30M |
December 31, 2023 | 71.50M |
September 30, 2023 | 66.95M |
June 30, 2023 | 63.74M |
March 31, 2023 | 60.18M |
December 31, 2022 | 54.24M |
September 30, 2022 | 57.31M |
June 30, 2022 | 56.11M |
March 31, 2022 | 48.13M |
December 31, 2021 | 42.02M |
September 30, 2021 | 37.95M |
June 30, 2021 | 35.02M |
March 31, 2021 | 31.20M |
Date | Value |
---|---|
December 31, 2020 | 28.16M |
September 30, 2020 | 32.43M |
June 30, 2020 | 21.21M |
March 31, 2020 | 19.30M |
December 31, 2019 | 17.16M |
September 30, 2019 | 15.74M |
June 30, 2019 | 13.60M |
March 31, 2019 | 13.56M |
December 31, 2018 | 11.49M |
September 30, 2018 | 8.407M |
June 30, 2018 | 6.541M |
March 31, 2018 | 6.166M |
December 31, 2017 | 4.313M |
September 30, 2017 | 3.466M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
17.16M
Minimum
Dec 2019
81.46M
Maximum
Jun 2024
47.34M
Average
48.13M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
ResMed Inc | 1.225B |
RxSight Inc | 34.89M |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 29.94M |
Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -85.57M |
Total Expenses (Quarterly) | 125.46M |
EPS Diluted (Quarterly) | -1.47 |
Enterprise Value | 2.146B |
Gross Profit Margin (Quarterly) | 43.30% |
Profit Margin (Quarterly) | -105.0% |
Earnings Yield | -9.11% |
Normalized Earnings Yield | -7.506 |